Skip to main content
. 2022 Jul 22;2022:8160144. doi: 10.1155/2022/8160144

Table 3.

Comparison of ECG parameters in patients with initially successful and failed RFCA (N = 154).

Initially success N = 136 Failure N = 18 P value
Interpolated VPCs (%) 23 (16.9%) 1 (5.6%) 0.310
Retrograde P-wave (%) 35 (25.7%) 4 (22.2%) 1
QRS ugly sign (%) 11 (8.1%) 2 (11.1%) 0.651
Pseudo delta wave (%) 22 (16.2%) 8 (44.4%) 0.009∗∗
QTc interval (ms) 430.38 ± 26.56 435.50 ± 28.25 0.978
QRS duration in lead II (ms) 151.51 ± 14.62 154.50 ± 22.83 0.068
R wave amplitude in lead II (mV) 1.88 ± 0.48 2.03 ± 0.40 0.290
QRS duration in lead III (ms) 148.33 ± 14.47 152.39 ± 18.51 0.219
R wave amplitude in lead III (mV) 1.80 ± 0.57 2.15 ± 0.74 0.209
QRS duration in lead aVF (ms) 149.12 ± 14.54 152.33 ± 35.42 0.081
R wave amplitude in lead aVF (mV) 1.82 ± 0.52 1.97 ± 0.53 0.339
Q wave amplitude in lead aVR (mV) 0.92 ± 0.22 1.00 ± 0.22 0.280
Q wave amplitude in lead aVL (mV) 0.81 ± 0.37 0.96 ± 0.41 0.333
R-wave ratio of leads III/II 0.98 ± 0.20 1.00 ± 0.24 0.715
Q-wave ratio of leads aVL/aVR 0.91 ± 0.43 0.91 ± 0.51 0.980
MDI of inferior lead 0.57 ± 0.08 0.58 ± 0.09 0.512
R wave amplitude in V1 (mV) 0.23 ± 0.24 0.35 ± 0.44 0.036∗
IDT in lead V2 (ms) 44.00 ± 18.33 57.41 ± 20.67 0.005∗∗
RS duration in V2 (ms) 93.67 ± 21.33 106.93 ± 18.76 0.004∗∗
QRS duration in V2 (ms) 147.82 ± 17.95 153.11 ± 16.61 0.205
R wave amplitude in V2 (mV) 0.42 ± 0.49 0.71 ± 0.58 0.056
S wave amplitude in V2 (mV) 1.94 ± 0.91 1.61 ± 1.04 0.145
R/S ratio in lead V2 0.21 ± 0.32 0.37 ± 0.90 0.032∗

P < 0.05, ∗∗P < 0.01.